Commonwealth Equity Services »

Cytomx Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $83k 53k 1.56
2023-09-30 $69k 53k 1.30
2023-06-30 $92k 53k 1.73
2023-03-31 $80k 53k 1.50
2022-12-31 $85k 53k 1.60

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Commonwealth Equity Services

Top funds holding Cytomx Therapeutics

BVF
Tang Capital Management
Vanguard Group
Laurion Capital Management
Bronte Capital Management Pty
Millennium Management
Jacobs Levy Equity Management
Assenagon Asset Management
Marshall Wace
BBK Capital Partners
Toroso Investments
Citadel Advisors
Bank of New York Mellon
Congress Park Capital
Clearline Capital

View all funds holding Cytomx Therapeutics